Aside from three primary central nervous system (CNS) tumors (2 oligodendrogliomas and 1 glioblastoma) with a single genetic lesion (IDH1 R132H mutation), no two patients within a given histology or organ-based diagnosis were molecularly identical (Table 2). This evidence concerns the gene IDH1 and glioblastoma.